Cytek Biosciences, Inc.
CTKB
$3.96
$0.195.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.27% | -0.08% | -0.11% | -1.35% | -4.41% |
| Total Receivables | -21.70% | 16.95% | 8.83% | 2.65% | -8.88% |
| Inventory | 3.55% | -6.27% | 3.94% | 9.40% | 3.72% |
| Prepaid Expenses | -44.29% | 141.84% | -29.24% | -7.78% | -33.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 128.54% | -72.98% | 1.52% | 5.19% | 30.45% |
| Total Current Assets | -3.24% | 0.90% | 1.48% | 0.61% | -4.02% |
|
|
|||||
| Total Current Assets | -3.24% | 0.90% | 1.48% | 0.61% | -4.02% |
| Net Property, Plant & Equipment | 6.10% | 0.41% | -15.93% | 25.40% | -1.52% |
| Long-term Investments | -0.05% | -0.01% | -0.05% | 0.17% | 0.09% |
| Goodwill | -0.05% | -0.01% | -0.05% | 0.17% | 0.09% |
| Total Other Intangibles | -6.64% | -4.84% | -4.97% | -4.27% | -3.46% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.80% | -87.63% | 6.19% | 5.90% | -3.80% |
| Total Assets | -2.69% | -6.74% | 0.32% | 2.22% | -3.38% |
|
|
|||||
| Total Accounts Payable | 5.16% | -16.01% | 11.37% | 9.70% | 12.99% |
| Total Accrued Expenses | -14.25% | 16.12% | -1.99% | 12.00% | -8.93% |
| Short-term Debt | 77.51% | 849.33% | -57.14% | -41.67% | -42.28% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.84% | -65.47% | 36.73% | 43.64% | -39.02% |
| Total Finance Division Other Current Liabilities | 5.15% | 5.18% | -0.87% | 3.99% | 6.65% |
| Total Other Current Liabilities | 5.15% | 5.18% | -0.87% | 3.99% | 6.65% |
| Total Current Liabilities | 4.02% | 3.45% | 2.64% | 8.24% | 0.04% |
|
|
|||||
| Total Current Liabilities | 4.02% | 3.45% | 2.64% | 8.24% | 0.04% |
| Long-Term Debt | -26.48% | -19.85% | -17.19% | -13.83% | -12.57% |
| Short-term Debt | 77.51% | 849.33% | -57.14% | -41.67% | -42.28% |
| Capital Leases | -4.28% | 4.06% | -4.43% | 89.57% | -1.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.64% | 1.63% | -2.14% | 2.48% | -2.12% |
| Total Liabilities | 1.39% | 2.97% | 0.51% | 12.42% | -0.76% |
|
|
|||||
| Common Stock & APIC | 1.05% | 1.34% | 1.31% | 0.69% | -0.95% |
| Retained Earnings | -18.54% | -76.44% | -10.50% | -11.98% | -32.39% |
| Treasury Stock & Other | 5.71% | 172.96% | 2,260.53% | 93.76% | -3,906.25% |
| Total Common Equity | -4.12% | -9.73% | 0.27% | -0.54% | -4.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.12% | -9.73% | 0.27% | -0.54% | -4.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.12% | -9.73% | 0.27% | -0.54% | -4.07% |
|
|
|||||